4-HO-DsBT
Chemical compound
From Wikipedia, the free encyclopedia
4-HO-DsBT, also known as 4-hydroxy-N,N-di-sec-butyltryptamine, is a tryptamine derivative which acts as a serotonin receptor agonist.[1][2]
Other names4-HO-DSBT; 4-Hydroxy-N,N-di-sec-butyltryptamine
CAS Number
- 127507-01-1

- 4-HO-DBT: 63065-89-4

| Clinical data | |
|---|---|
| Other names | 4-HO-DSBT; 4-Hydroxy-N,N-di-sec-butyltryptamine |
| Identifiers | |
| |
| CAS Number |
|
| PubChem CID | |
| ChemSpider | |
| UNII |
|
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C18H28N2O |
| Molar mass | 288.435 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Use and effects
4-HO-DsBT was first made by Alexander Shulgin and is mentioned in his book TiHKAL (Tryptamines I Have Known and Loved), but was never tested by him.[1]
Interactions
Pharmacology
Chemistry
Analogues
Analogues of 4-HO-DsBT include 4-HO-DBT, 4-HO-DiBT, 4-HO-DtBT, 4-HO-DiPT, 4-HO-McPeT, 4-HO-PiPT, 5-MeO-DBT, dibutyltryptamine (DBT), and N-tert-butyltryptamine (NtBT), among others.
History
4-HO-DsBT was first described in the scientific literature by David Repke and colleagues by 1981.[3]